OpenEye, Cadence Molecular Sciences

OpenEye's Arghya Chakravorty will present "From a few billions to a few: Computer-Aided Drug design on the Cloud" at The University of New Mexico Department of Chemistry and Chemical Biology's Weekly Seminar series today. The talk will present solutions to a variety of problems in the drug discovery process that are widely used in industry with a focus on the contribution that free energy estimation by molecular dynamics (MD) simulation can make to molecular design, and the utility of cloud computing in enabling MD simulation at scale.

The full agenda for CUP XXIV is now available! Join us for an exciting lineup of talks and discussions on the latest breakthroughs and challenges in drug discovery. We can’t wait for a fantastic week of science in Santa Fe—see you there! #CUPXXIV #DrugDiscovery

When coupled with a physics-based approach, AI is an effective tool for drug discovery. Watch Anthony Nicholls, PhD, discuss how to best utilize AI in early-stage drug discovery process. Cadence #drugdiscovery #aidrugdiscovery #lifesciences

We are excited to be attending the BMCS 2nd Conformational Design in Drug Discovery 2025 on March 3rd in Cambridge! Let’s connect and discuss how our cutting-edge molecular modeling solutions can accelerate your research! See you there! #DrugDiscovery #MolecularModeling

Watch: Geoff Skillman, PhD discusses the CUP XXIV agenda and keynote speakers. There is still time to register to attend CUP! CUP XXIV ?? March 4-6th ?? Santa Fe, New Mexico Register: https://lnkd.in/eXu6puvq

Upcoming Webinar: Optimizing lead compounds with efficient binding free energy calculations Join us on February 20th as we explore how OpenEye’s cloud-native modeling platform, Orion?, enables more accurate and efficient ligand ranking for lead optimization using nonequilibrium switching (NES). ?? Save your spot today! #DrugDiscovery #ComputationalChemistry #MolecularModeling

Did you know that OpenEye builds custom software around your specific drug discovery needs? Learn about Feature Acceleration Agreements (FAA) now! https://lnkd.in/edxkqjYm

Sygnature Discovery relies on OpenEye’s Orion cloud modeling platform for large-scale virtual screening (giga-scale docking) to quickly identify hits for their customers and scientists. Ready to enhance your virtual screening process? Learn how Orion can also help you: https://lnkd.in/emMTbSfK #DrugDiscovery #VirtualScreening #StrongFoundation #MolecularDocking

??There is still time to register for CUP XXIV! ?? Join top industry experts at OpenEye's premier event for cutting-edge science, industry talks, and powerful networking. This year we will feature two keynote speakers - Dr. Jeff Blaney, Sr. Director, Discovery Chemistry at Genentech and Dr. Ken Dill, Laufer Family Endowed Professor, Stony Brook University. ?? March 4-6, 2025 ?? Santa Fe, NM Register now! #CUPXXIV #DrugDiscovery

Heard of Orion but not exactly sure how you could use it in your day-to-day project work? Come see the latest version as well as the ultra fast standalone Molecule Search functionality which can be used by anyone, even without computational expertise! We invite you to join us for a hands-on demonstration on February 11th in Cambridge where you will run your own Virtual Screen in a casual group setting. Check out the full event details here: https://lnkd.in/eHqEmtfM